GEODON

This brand name is authorized in Brazil, Cyprus, Ireland, Israel, Mexico, United States, South Africa

Active ingredients

The drug GEODON contains one active pharmaceutical ingredient (API):

1 Ziprasidone UNII 216X081ORU - ZIPRASIDONE HYDROCHLORIDE

Ziprasidone has been shown to be an antagonist at both serotonin type 2A (5HT2A) and dopamine type 2 (D2) receptors. It is proposed that the therapeutic activity is mediated, in part, through this combination of antagonist activities. Ziprasidone is also a potent antagonist at 5HT2C and 5HT1D receptors, a potent agonist at the 5HT1A receptor and inhibits neuronal reuptake of norepinephrine and serotonin. Read about Ziprasidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GEODON Powder for solution for injection	Web Search	MPI, EU: SmPC
GEODON Capsule, hard	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AE04	Ziprasidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 552820050066817, 552820050066917, 552820050067017, 552820050067117
Country: IE	Health Products Regulatory Authority	Identifier(s): 36016, 36017, 36018, 39567, 55525, 56729, 73336
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4500, 4502, 4504, 4506
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 318M2001, 346M2002
Country: US	FDA, National Drug Code	Identifier(s): 0049-0052, 0049-0054, 0049-0056, 0049-0058, 0049-1203, 0049-3920, 0049-3960, 0049-3980, 0049-3990, 50090-4540, 70518-1373
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/2.6.5/0584, 32/2.6.5/0585, 32/2.6.5/0586, 32/2.6.5/0587